| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 525.97M | 891.66M | 247.46M | 1.74B | 426.88M |
| Gross Profit | 204.36M | 296.03M | 97.53M | 484.63M | 169.43M |
| EBITDA | 114.55M | 172.73M | 54.27M | 627.52M | 130.14M |
| Net Income | 18.90M | 52.45M | 18.59M | 259.12M | 57.54M |
Balance Sheet | |||||
| Total Assets | 3.73B | 4.26B | 4.83B | 4.62B | 5.17B |
| Cash, Cash Equivalents and Short-Term Investments | 132.31M | 184.41M | 434.57M | 291.70M | 299.38M |
| Total Debt | 593.85M | 621.25M | 480.24M | 482.23M | 607.31M |
| Total Liabilities | 1.78B | 2.25B | 2.84B | 2.60B | 3.51B |
| Stockholders Equity | 1.75B | 1.73B | 1.68B | 1.71B | 1.41B |
Cash Flow | |||||
| Free Cash Flow | 78.07M | -38.06M | 115.24M | 182.65M | -338.13M |
| Operating Cash Flow | 82.22M | -22.84M | 123.12M | 212.33M | -318.69M |
| Investing Cash Flow | 1.16M | -9.06M | -32.56M | -43.13M | 170.25M |
| Financing Cash Flow | -75.50M | 20.28M | -87.20M | -169.24M | 23.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$538.37M | 1.31 | 8.62% | 6.25% | 2.42% | 10.16% | |
73 Outperform | HK$272.80M | 1.06 | 15.77% | 11.22% | 11.13% | 142.00% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | HK$211.90M | 6.11 | -0.02% | ― | -68.21% | -100.40% | |
56 Neutral | HK$256.01M | 3.99 | 6.98% | 3.90% | -3.62% | 26.66% | |
50 Neutral | HK$169.52M | 1.12 | 2.01% | ― | -8.64% | ― | |
43 Neutral | HK$111.94M | -0.35 | 13.47% | ― | -7.52% | -5.99% |